CII
JNJ icon

CR Intrinsic Investors’s Johnson & Johnson JNJ Stock Holding History

CR Intrinsic Investors’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-250,000
Closed -$23.2M – 297
2013
Q4 		$22.9M Buy
+250,000
New +$23M 0.99% 16

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

CR Intrinsic Investors's JNJ Position: Q1 2014 in Review

CR Intrinsic Investors sold out of Johnson & Johnson (JNJ) in Q1 2014, closing a stake of 250,000 shares — an estimated $23.2M sold.

CR Intrinsic Investors first reported a position in JNJ in Q4 2013 and held it in 1 quarter. The position peaked at $22.9M in Q4 2013. 1,973 funds tracked by Wall St. Rank hold JNJ as of Q1 2014.

  • CR Intrinsic Investors reported no remaining Johnson & Johnson position as of Q1 2014 after selling out during the quarter.
  • CR Intrinsic Investors sold 250,000 Johnson & Johnson shares in Q1 2014, an estimated $23.2M.
  • CR Intrinsic Investors first reported a position in Johnson & Johnson in Q4 2013 and held it in 1 quarter.
  • CR Intrinsic Investors's Johnson & Johnson position peaked at $22.9M in Q4 2013.
  • 1,973 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2014.

Based on CR Intrinsic Investors's 13F filing for Q1 2014, filed 15 May 2014.